Showing 1–16 of 16 results
-
Research |
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
- W. Wiktor-Jedrzejczak
- , J. Drozd-Sokolowska
- , D. J. Eikema
- , J. Hoek
- , M. Potter
- , G. Wulf
- , L. Sellner
- , P. Ljungman
- , P. Chevallier
- , L. Volin
- , Y. Koc
- , S. Martin
- , D. Bunjes
- , M. Rovira
- , M. Itälä-Remes
- , R. Foá
- , E. Deconinck
- , T. Gedde-Dahl
- , J. Cornelissen
- , M. Collin
- , A. Brecht
- , A. Patel
- , M. de Groot
- , P. Reményi
- , A. Nagler
- , J. Finke
- , P. Turlure
- , S. Iacobelli
- , A. van Biezen
- , J. Schetelig
- , N. Kröger
- & P. Dreger
-
Research | | Open
-
Research |
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
- A Stamatoullas
- , P Brice
- , M S Gueye
- , S Mareschal
- , P Chevallier
- , R Bouabdallah
- , S Nguyenquoc
- , S Francois
- , P Turlure
- , P Ceballos
- , H Monjanel
- , J-H Bourhis
- , G Guillerm
- , M Mohty
- , P Biron
- , J Cornillon
- , K Belhadj
- , C Bonmati
- , M-S Dilhuydy
- , A Huynh
- , M Bernard
- , M-L Chrétien
- , R Peffault de Latour
- & H Tilly
Bone Marrow Transplantation 51 , 928–932 -
Research |
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
- J Gauthier
- , L Castagna
- , F Garnier
- , T Guillaume
- , G Socié
- , S Maury
- , N Maillard
- , R Tabrizi
- , T Marchand
- , J Malfuson
- , A Gac
- , E Gyan
- , M Mercier
- , Y Béguin
- , J Delage
- , P Turlure
- , A Marçais
- , S Nguyen
- , R Dulery
- , J Bay
- , A Huynh
- , E Daguindau
- , J Cornillon
- , C Régny
- , M Michallet
- , R Peffault de Latour
- , I Yakoub-Agha
- & D Blaise
Bone Marrow Transplantation 52 , 689–696 -
Research |
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
- A-C Mamez
- , V Lévy
- , P Chevallier
- , D Blaise
- , S Vigouroux
- , A Xhaard
- , N Fegueux
- , N Contentin
- , Y Beguin
- , N Ifrah
- , C-E Bulabois
- , F Suarez
- , I Yakoub-Agha
- , P Turlure
- , E Deconink
- , T Lamy
- , J Y Cahn
- , A Huynh
- , S Maury
- , L M Fornecker
- , M Ouzegdouh
- , J-O Bay
- , G Guillerm
- , N Maillard
- , M Michallet
- , J-V Malfuson
- , J-H Bourhis
- , F Rialland
- , R Oumedaly
- , C Jubert
- , V Leblond
- , M Boubaya
- , M Mohty
- & S Nguyen
Bone Marrow Transplantation 51 , 358–364 -
-
-
-
Research |
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia
- D Rea
- , L Legros
- , E Raffoux
- , X Thomas
- , P Turlure
- , S Maury
- , B Dupriez
- , A Pigneux
- , B Choufi
- , O Reman
- , D Stéphane
- , B Royer
- , M Vigier
- , M Ojeda-Uribe
- , C Recher
- , H Dombret
- , F Huguet
- & P Rousselot
Leukemia 20 , 400–403 -
Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial
- P Chevallier
- , L Fornecker
- , B Lioure
- , M C Béné
- , A Pigneux
- , C Recher
- , B Witz
- , N Fegueux
- , C-E Bulabois
- , S Daliphard
- , D Bouscary
- , N Vey
- , M Delain
- , J-O Bay
- , P Turlure
- , M Bernard
- , C Himberlin
- , I Luquet
- , N Ifrah
- & J-L Harousseau
Leukemia 24 , 1380–1385 -
Research |
-
-
Research |
-
Research |
-
-
Research |
